Announcements Trials
Browse Landscape

Status

Available 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 263Observational 39Expanded_access 2

Sponsor

Cancer Type

Thoracic 8Sarcoma 7Genitourinary 5Gastrointestinal 5CNS 5Other hematologic neoplasm 4Lymphoid 4Breast 4Tumor-Agnostic 2Myeloid 2Gynecologic 2Dermatologic 2Plasma cell 1Head & Neck 1Endocrine 1

Conditions

Myelodysplastic Syndromes 1Mastocytosis, Systemic 1Leukemia, Myeloid, Acute 1Leukemia, Mast-Cell 1Hematologic Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Expanded_access × Myeloid × 90 days × Clear all
NCT06915766 2026-05-08

Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis

Cogent Biosciences, Inc.

Available
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Mast-Cell, Mastocytosis, Systemic

NCT05593185 2026-04-24

Expanded Access Program (EAP) for Galinpepimut-S (GPS) in Patients Diagnosed With AML or MDS

Sellas Life Sciences Group

Available
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡